laquinimod topical (TV-5600) / Active Biotech - LARVOL DELTA

Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study (clinicaltrials.gov) - P1 | N=12 | Recruiting | Sponsor: Quan Dong Nguyen | Trial completion date: Apr 2025 ➔ Jul 2025 | Trial primary completion date: Jan 2025 ➔ Jul 2025

Trial completion date • Trial primary completion date • Inflammation • Ocular Inflammation • Ophthalmology • Uveitis

Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study (clinicaltrials.gov) - P1 | N=12 | Recruiting | Sponsor: Quan Dong Nguyen | Trial completion date: Oct 2024 ➔ Feb 2025 | Trial primary completion date: Aug 2024 ➔ Dec 2024

Immunomodulating • Trial completion date • Trial primary completion date • Inflammation • Ocular Inflammation • Ophthalmology • Uveitis

Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study (clinicaltrials.gov) - P1 | N=12 | Recruiting | Sponsor: Quan Dong Nguyen | Not yet recruiting ➔ Recruiting

Enrollment open • Immunomodulating • Inflammation • Ocular Inflammation • Ophthalmology • Uveitis

LION: Safety, Tolerability, and Distribution of Topical Laquinimod Eye Drops : a Phase 1 Study (clinicaltrials.gov) - P1 | N=12 | Not yet recruiting | Sponsor: Quan Dong Nguyen

Immunomodulating • New P1 trial • Ocular Inflammation • Ophthalmology • Uveitis

A Study of Laquinimod Eye-drops in Healthy Participants (clinicaltrials.gov) - P1 | N=54 | Completed | Sponsor: Active Biotech AB | Active, not recruiting ➔ Completed

Trial completion • Ophthalmology

A Study of Laquinimod Eye-drops in Healthy Participants (clinicaltrials.gov) - P1 | N=56 | Active, not recruiting | Sponsor: Active Biotech AB | Recruiting ➔ Active, not recruiting

Enrollment closed • Ophthalmology

A Study of Laquinimod Eye-drops in Healthy Participants (clinicaltrials.gov) - P1 | N=56 | Recruiting | Sponsor: Active Biotech AB | N=42 ➔ 56 | Trial completion date: Jun 2022 ➔ Mar 2023 | Trial primary completion date: May 2022 ➔ Jan 2023

Enrollment change • Trial completion date • Trial primary completion date • Ophthalmology

A Study of Laquinimod Eye-drops in Healthy Participants (clinicaltrials.gov) - P1; N=42; Recruiting; Sponsor: Active Biotech AB

Clinical • New P1 trial • Ophthalmology